Showing results (321-330 of 404) with videos related to
Sort By:
Pageof 41
Schizophrenia Research|May 5, 1999
Problem-solving and spatial working memory in patients with schizophrenia and with focal frontal and temporal lobe lesionsT M Rushe, R G Morris, E C Miotto, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|July 19, 2001
Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive declineM T Hu, S J White, K R Chaudhuri, et al.European Journal of Clinical Pharmacology|January 1, 1990
Interference from digoxin-like immunoreactive substance(s) in commercial digoxin kit assay methodsR G Morris, D B Frewin, N C Saccoia, et al.Therapeutic Drug Monitoring|August 12, 1999
Some international approaches to aminoglycoside monitoring in the extended dosing interval eraR G Morris, B C Sallustio, A A Vinks, et al.Cancer Chemotherapy and Pharmacology|January 1, 1987
Effect of L-leucine on oral melphalan kinetics in patientsP A Reece, B M Dale, R G Morris, et al.Therapeutic Drug Monitoring|June 1, 1987
Spironolactone as a source of interference in commercial digoxin immunoassaysR G Morris, P Y Lagnado, D R Lehmann, et al.American Journal of Clinical Oncology|August 1, 1990
A phase I study of doxifluridine as a five-day stepped-dose continuous infusionI N Olver, P A Reece, J F Bishop, et al.The Medical Journal of Australia|October 7, 1996
Drugs and brain deathM C Kennedy, J L Moran, M Fearnside, et al.Brain : a Journal of Neurology|June 1, 1988
A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's diseaseB J Sahakian, R G Morris, J L Evenden, et al.Clinical Chemistry|September 11, 1998
Evaluation of the tacrolimus II microparticle enzyme immunoassay (MEIA II) in liver and renal transplant recipientsJ L Cogill, P J Taylor, I S Westley, et al.Pageof 41